BCL2L1 and neoplasm: Comparing tumor-infiltrating versus blood Treg cells, we identified some common shared signature genes of tumor-infiltrating Treg cells, including some genes whose protein products are targetable such as CD177 and BCL2L1 (encoding BCL-XL).